Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|16-23

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 16-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 93-100

Bentham Science Publishers

Access to resources Recommend Favorite

Decoding the ‘embryonic’ nature of embryonal rhabdomyosarcoma

By  

Journal of Developmental Origins of Health and Disease, Vol. 6, Iss. 3, 2015-03 ,pp. : 163-168

Cambridge University Press

Access to resources Recommend Favorite

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergy and Tumour Outcome after Primary Cancer Therapy

By  

International Archives of Allergy and Immunology, Vol. 133, Iss. 2, 2004-02 ,pp. : 174-178

Karger

Access to resources Recommend Favorite